Table 5 Clinical characterisation of AD patients with SEA and those without
|  | SEA (n = 13) | No SEA (n = 28) | P-value |
|---|---|---|---|
Age at NPT | 68 [67;75] | 71 [68;73.25] | 0.448 |
Age at disease onset | 65 [61;72] | 68 [65;71.5] | 0.448 |
Disease duration (years) | 3 [3;4] | 3 [2;4] | 0.678 |
Education duration (years) | 16 [12;17] | 14 [10.5;15] | 0.167 |
Female sex | 7 (54%) | 13 (46%) | 0.744 |
Arterial hypertension | 5 (38%) | 15 (54%) | 0.505 |
Dyslipidemia | 11 (85%) | 20 (71%) | 0.458 |
Smoking | 1 (8%) | 3 (11%) | 1.000 |
Diabetes mellitus | 2 (15%) | 2 (7%) | 0.579 |
Anti-AD medication | 10 (77%) | 26 (93%) | 0.304 |
Sleep medication | 3 (23%) | 9 (32%) | 0.719 |
Antidepressants | 5 (38%) | 10 (36%) | 1.000 |
TST (hours) | 8.25 [7;8.87] | 8.125 [6.8125;9] | 0.900 |
Time to sleep onset (minutes) | 10 [5;15] | 15 [8.125;17.25] | 0.347 |